The development of targeted medicine has greatly expanded treatment options and spurred
new research avenues in cancer therapeutics, with monoclonal antibodies (mAbs) emerging …

Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …

With the rapid increase in the incidence of cervical cancer, anal cancer and other cancers,
human papillomavirus (HPV) infection has become a growing concern. Persistent infection …

For treatment and diagnosis of cancer, antibodies have proven their value and now serve as
a first line of therapy for certain cancers. A unique class of antibody fragments called …

Infectious diseases, caused by pathogenic microorganisms, are capable of affecting crises.
In addition to persistent infectious diseases such as malaria and dengue fever, the vicious …

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has resulted in over 100 million infections and millions of deaths. Effective vaccines remain …

Targeted therapy is a fast evolving treatment strategy to reduce unwanted damage to
healthy tissues, while increasing efficacy and specificity. Driven by state-of-the-art …

The immune system's ability to recognize peptides on major histocompatibility molecules
contributes to the eradication of cancers and pathogens. Tracking these responses in vivo …

The emergence of SARS‐COV‐2, the causative agent of new coronavirus disease (COVID‐
19) has become a pandemic threat. Early and precise detection of the virus is vital for …

Cancer is a heterogeneous disease, requiring treatment tailored to the unique phenotype of
the patient's tumor. Monoclonal antibodies (mAbs) and variants thereof have enabled …